| ACT M(SD) | TAU M(SD) | Change t(df) |
---|---|---|---|
Change EDE-Q global score | 1.54 (1.34), N = 37 | 0.66 (1.55), N = 40 | − 2.67 (75)** |
AN spectrum | 1.56 (1.34), N = 17 | 0.47 (1.55), N = 22 | − 2.32 (37)* |
BN spectrum | 1.53 (1.37), N = 20 | 0.90 (1.55), N = 18 | − 1.33 (36) |
Age < 25 at inclusion | 1.72 (1.22), N = 19 | 0.00 (1.39), N = 18 | − 4.00 (35)*** |
Age ≥ 25 at inclusion | 1.36 (1.46), N = 18 | 1.20 (1.48), N = 22 | − 0.33 (38) |
Treatment duration < 12 months | 1.85 (1.32), N = 24 | 0.73 (1.79), N = 24 | − 2.48 (46)* |
Treatment duration ≥ 12 months | 0.98 (1.23), N = 13 | 0.57 (1.13), N = 16 | − 0.94 (27) |
MADRS-S < 20 | 1.43 (1.41), N = 22 | 0.62 (1.47), N = 22 | − 1.86 (42) |
MADRS-S ≥ 20 | 1.76 (1.34), N = 13 | 1.10 (1.60), N = 12 | − 1.11 (23) |
EDE-Q T1 < 2.76 | 0.90 (1.04), N = 11 | − 0.25 (1.24), N = 14 | − 2.53 (23)* |
EDE-Q T1 ≥ 2.76 | 1.82 (1.37), N = 26 | 1.16 (1.49), N = 26 | − 1.67 (50) |
 | N (expected) | N (expected) | χ2 (df) |
---|---|---|---|
Subjectively recovered, YES | 23 (18.5) | 15 (19.5) | 4.27 (1)* |
Subjectively recovered, NO | 14 (18.5) | 24 (19.5) | Â |